Perspective Therapeutics (CATX) Debt Ratio (2023 - 2026)

Perspective Therapeutics (CATX) reported Debt Ratio of 0.0 for Q1 2026, down 22.66% on a YoY basis from 0.0 in Q1 2025, and down 35.63% sequentially from 0.01 in Q4 2025.

Perspective Therapeutics (CATX) Debt Ratio (2023 - 2026) Analysis & Trends

Perspective Therapeutics (CATX) has 4 years of Debt Ratio data on file, last reported at 0.0 in Q1 2026.

  • For the quarter ending Q1 2026, Debt Ratio fell 22.66% year-over-year to 0.0; the trailing twelve-month figure through Mar 2026 stood at 0.0 (down 22.66% YoY), and the FY2025 full-year result was 0.01, up 23.36% from the prior year.
  • Debt Ratio retreated to 0.0 in Q1 2026, from 0.01 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.02 in Q4 2023 to a low of 0.0 in Q1 2026.
  • A 4-year average of 0.01 and a median of 0.01 in 2025 frame the typical range for Debt Ratio.
  • Across the five-year window, Debt Ratio sank 73.36% in 2024 and gained 28.22% in 2025, its largest moves.
  • Tracing CATX's Debt Ratio over 4 years: stood at 0.02 in 2023, then plunged by 72.17% to 0.0 in 2024, then rose by 23.36% to 0.01 in 2025, then plunged by 35.63% to 0.0 in 2026.
  • Business Quant data shows CATX's Debt Ratio at 0.0 in Q1 2026, 0.01 in Q4 2025, and 0.01 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 0.31
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 0.32
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 0.30
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 0.25
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 0.04
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 0.30
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 0.27
9 Smith & Nephew 25.80 Bn 25.22 Bn - 0.30
10 Perspective Therapeutics 146.05 Mn 146.05 Mn - 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.01
Dec 31, 2023 0.02
Sep 30, 2023 0.02
Jun 30, 2023 0.01
Mar 31, 2023 0.01